The University of Modena and Reggio Emilia, located in Modena and Reggio Emilia, Emilia-Romagna, Italy, is one of the oldest universities in Italy, founded in 1175, with a population of 20,000 students.

During the past decade, University of Modena and reggio emilia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Modena and reggio emilia" #1 sponsor was "University of Modena and Reggio Emilia" with 8 trials, followed by "Ariad Pharmaceuticals" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Clovis Oncology, Inc." with 1 trials sponsored and "Erasmus Medical Center" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Modena and reggio emilia" #1 collaborator was "Agenzia Italiana del Farmaco" with 1 trials as a collaborator, "Arcispedale Santa Maria Nuova-IRCCS" with 1 trials as a collaborator, "Azienda Ospedaliera di Bolzano" with 1 trials as a collaborator, "Azienda Ospedaliero-Universitaria di Modena" with 1 trials as a collaborator and "Azienda Unità Sanitaria Locale Reggio Emilia" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "University of Modena and reggio emilia" are "Hypertension in Pregnancy" (2 trials), "Bronchiectasis" (1 trials), "Cervical Shortening" (1 trials), "Chronic Myeloid Leukemia" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "University of Modena and reggio emilia" in a lesser frequency.

Most popular intervention types in "University of Modena and reggio emilia" are "Drug" (8 trials), "Procedure" (4 trials), "Other" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "17 alpha-hydroxy progesterone caproate" (1 trials), "AZLI" (1 trials), "Abiraterone acetate or Enzalutamide or Docetaxel" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Modena and reggio emilia" are 11 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Modena and reggio emilia". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in University of Modena and reggio emilia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Modena and reggio emilia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".